Disease Activity Indices in Systemic Lupus Erythematosus: What Is New?
Systemic lupus erythematosus (SLE) is a complicated multisystem autoimmune disease that carries substantial mortality and morbidity. The development of new therapies is partly hindered by the lack of a flawless instrument to gauge disease activity in different organs for the primary efficacy outcome...
Main Authors: | Fung Lam, Chi Chiu Mok |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2023-12-01
|
Series: | Journal of Clinical Rheumatology and Immunology |
Subjects: | |
Online Access: | https://www.worldscientific.com/doi/10.1142/S2661341723300057 |
Similar Items
-
Influence of prolactin and estrogen on disease activity in patients with systemic lupus erythematosus
by: Marwa Mahmoud Abdelaziz, et al.
Published: (2018-01-01) -
Interleukin-6 and disease activity in childhood systemic lupus erythematosus
by: Cahya Dewi Satria, et al.
Published: (2023-11-01) -
Herpes zoster vaccination in systemic lupus erythematosus: the current status
by: Chi Chiu Mok
Published: (2019-01-01) -
SEVERITY INDEX IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: N. G. Klyukvina, et al.
Published: (2014-09-01) -
Cutaneous lupus erythematosus disease assessment: Highlighting CLE outcome measures
by: Rebecca G. Gaffney, et al.
Published: (2022-10-01)